Optimer Pharmaceuticals Inc (NASDAQ:OPTR.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products.

Recs

2
Player Avatar mamastox (< 20) Submitted: 5/28/2011 1:31:22 PM : Outperform Start Price: $13.70 OPTR.DL Score: -36.25

FDA approval for Dificid to treat gram positive( C-diff) bacteria, a potentially deadly superbug which causes,clostridium difficile associated diarreah. (CDAD ). This is an alternative drug to Vancomycin which has been the main antibiotic to treat c-diff. In bed with cubist pharmaceuticals.

Featured Broker Partners


Advertisement